https://www.selleckchem.com/pr....oducts/SB-202190.htm
Those with early conversions and creatinine 2.0 mg/dL at the time of conversion had the best response. A large variety of belatacept conversion protocols were identified. Protocols were defined by the initial dose, induction regimen, and CNI taper. Rejection rates were low and may be influenced by exposure to maintenance immunosuppression during and after conversion. Most patients showed stabilization and improvement in creatinine postconversion, with the largest effect in those with an early conversion and serum creatinine 2.
Beğen
Yorum Yap
Paylaş
